Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Genetronics cleared to proceed with electroporation trial in France

Nov. 6, 1997

CellPro: Q2 1997 highlights

Nov. 6, 1997

Karo Bio/Merck & Co. form strategic alliance related to ER receptors

Nov. 5, 1997

FibroGen granted license to Zeneca antifibrotic compounds

Nov. 3, 1997

Genzyme General and Acadia enter drug discovery collaboration

Nov. 3, 1997

Laminin-like peptides available for licensing from NIH

Nov. 3, 1997

Genetic animal model of psychiatric disorders available for licensing

Oct. 30, 1997

Lilly and Chugai enter into combinatorial chemistry collaboration

Oct. 29, 1997

Dyax and Tularik establish drug discovery collaboration

Oct. 28, 1997

Structure of NO-producing enzyme solved

Oct. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...